Clin2
NCT07751094Possibly a fitNot yet recruiting

Drug interaction study for chronic pain

Chronic Pain

Part of Pain clinical trials.

This study tests how two pain medications interact when given together. It is for adults with chronic pain (not from cancer) and may help doctors understand how to combine these drugs safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
27 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You need to be between 18 and 55 years old.
  • You must have moderate to severe chronic pain that is not caused by cancer (for example, chronic back pain or shoulder inflammation), with a pain score of at least 4 on a 0-10 scale.
  • Your weight must be at least 50 kg (110 lbs) for men and 45 kg (99 lbs) for women, and your body mass index (BMI) must be between 19 and 26.
  • You must agree to use effective contraception and not donate sperm or eggs during the study and for 3 months after.
  • You cannot have any serious health problems like heart disease, mental illness, asthma, or a history of drug or alcohol abuse.
  • You must be able to avoid certain foods, drinks, and medications during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07710560Not yet recruiting· Phase 1
Study on interaction between KL0011034 and alfentanil for chronic pain

This trial tests how a new pain medication, KL0011034, interacts with another drug called alfentanil in people with moderate-to-severe chronic pain that is not caused by cancer. It helps understand if the drugs can be given together safely.

Changsha, Hunan
NCT07618247Not yet recruiting· Phase 1
Testing a new drug in healthy adults

This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.

Adelaide, South Australia
NCT07504601Not yet recruiting· Phase 2
Testing a ketamine-related drug for short-term pain in healthy adults

This study tests whether a new drug called (2R,6R)-HNK can reduce pain caused by heat in healthy volunteers. The results will help researchers understand if this drug might be useful for treating acute (short-lasting) pain in the future.

Bethesda, Maryland
NCT07551739Not yet recruiting· Phase 2
Testing a new pain medication after orthopedic surgery

This study tests a new medication called HSK55718 to help manage pain after orthopedic (bone and joint) surgery. Researchers want to see if it works better or as well as other pain treatments and is safe to use.

NCT07323914Recruiting· Phase 3
Pain management for people with Alzheimer's and chronic pain

This study tests if opioid pain medicine is safe and effective for people with Alzheimer's disease who also have chronic pain. It aims to find better ways to manage pain in dementia.

Beijing
NCT05986292Recruiting· Phase 2
Study of new treatments for chronic pain

This study tests new treatments for chronic pain that lasts at least 3 months. Participants must stop their regular pain medicines and use only a rescue painkiller if needed. The goal is to find better ways to manage long-term pain.

Birmingham, Alabama

Hear when a new Chronic pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.